The trial will include patients with locally advanced or metastatic HER2-positive, PD-L1-positive gastric or gastroesophageal junction cancer.

Gastric cancer (GC) is a leading cause of cancer-related deaths worldwide, with more than one million new diagnoses annually.

A new form of tumor infiltrating lymphocyte (TIL) therapy, a form of personalized cancer immunotherapy, dramatically improved the treatment's effectiveness in patients with metastatic gastrointestinal ...

Yelena Y. Janjigian, MD, discusses the standard approval of pembrolizumab plus trastuzumab and chemotherapy for the treatment ...

The largest ever clinical trial compared obesity operations in 1,346 NHS patients, and one explains: "I felt everyone was looking at me all the time because of my size" ...

Gastric05 Phase 3 Trial of ENHERTU® Initiated in Patients with Previously Untreated HER2 Positive Advanced Gastric Cancer ...

Akeso Inc. (9926.HK) ("Akeso", "the Company") released its 2024 annual report, emphasizing the company's key achievements in drug research, clinical development, and commercialization.

Jak Cleland’s mum Jeanette was diagnosed with the disease in early 2019, and on February 6 2020, she passed away after a brave but gruelling battle. The 54-year-old finished treatment in October 2020, ...

Bachelorette’ alum Katie Thurston announced that her stage 4 breast cancer has spread to her liver on Friday, March 28 ...

Mother-of-four Camilla Chapman, 40, was diagnosed with stomach cancer after assuming her difficulty swallowing was a side effect of a weight loss diet ...

PRINCE GEORGE – In November of 2024, Greg Hoff was diagnosed with esophageal carcinoma, a type of stomach cancer. Since ...

Radiopharm Theranostics Limited targets oncology with radiotherapeutics like Lu-RAD204 for NSCLC. Key 2025 data signals ...